These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 24726886

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Adenovirus-mediated tBid overexpression results in therapeutic effects on p53-resistant hepatocellular carcinoma.
    Miao J, Chen GG, Chun SY, Yun JP, Chak EC, Ho RL, Lai PB.
    Int J Cancer; 2006 Oct 15; 119(8):1985-93. PubMed ID: 16708390
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma.
    Hallenbeck PL, Chang YN, Hay C, Golightly D, Stewart D, Lin J, Phipps S, Chiang YL.
    Hum Gene Ther; 1999 Jul 01; 10(10):1721-33. PubMed ID: 10428217
    [Abstract] [Full Text] [Related]

  • 8. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
    Ido A, Uto H, Moriuchi A, Nagata K, Onaga Y, Onaga M, Hori T, Hirono S, Hayashi K, Tamaoki T, Tsubouchi H.
    Cancer Res; 2001 Apr 01; 61(7):3016-21. PubMed ID: 11306481
    [Abstract] [Full Text] [Related]

  • 9. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
    Wei RC, Cao X, Gui JH, Zhou XM, Zhong D, Yan QL, Huang WD, Qian QJ, Zhao FL, Liu XY.
    Hum Gene Ther; 2011 Sep 01; 22(9):1109-19. PubMed ID: 21361790
    [Abstract] [Full Text] [Related]

  • 10. [Detection and comparison of transcriptional activities of tumor-specific survivin and alpha-fetoprotein promoters in human hepatocellular carcinoma cells].
    Kuang G, Huang AL, Tang N.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jun 01; 13(6):440-2. PubMed ID: 15975279
    [Abstract] [Full Text] [Related]

  • 11. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
    Kanai F, Shiratori Y, Yoshida Y, Wakimoto H, Hamada H, Kanegae Y, Saito I, Nakabayashi H, Tamaoki T, Tanaka T, Lan KH, Kato N, Shiina S, Omata M.
    Hepatology; 1996 Jun 01; 23(6):1359-68. PubMed ID: 8675152
    [Abstract] [Full Text] [Related]

  • 12. [Gene therapy using a dominant negative form of the protein phosphatase 2A catalytic subunit a driven by a hepatoma tissue-specific promoter achieves effective growth inhibition of hepatoma cells].
    Li DM, Li W, Tao M, Chen K, Gong FR, Xu ZK, Chen Z.
    Zhonghua Gan Zang Bing Za Zhi; 2013 Jun 01; 21(6):459-63. PubMed ID: 24034849
    [Abstract] [Full Text] [Related]

  • 13. Tumor-targeted gene therapy using Adv-AFP-HRPC/IAA prodrug system suppresses growth of hepatoma xenografted in mice.
    Dai M, Liu J, Chen DE, Rao Y, Tang ZJ, Ho WZ, Dong CY.
    Cancer Gene Ther; 2012 Feb 01; 19(2):77-83. PubMed ID: 21959967
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Gene therapy for hepatocellular carcinoma based on tumour-selective suicide gene expression using the alpha-fetoprotein (AFP) enhancer and a housekeeping gene promoter.
    Cao G, Kuriyama S, Gao J, Nakatani T, Chen Q, Yoshiji H, Zhao L, Kojima H, Dong Y, Fukui H, Hou J.
    Eur J Cancer; 2001 Jan 01; 37(1):140-7. PubMed ID: 11165141
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A novel approach for inducing enhanced and selective transgene expression in hepatocellular-carcinoma cells.
    Cao G, Kuriyama S, Tsujinoue H, Chen Q, Mitoro A, Qi Z.
    Int J Cancer; 2000 Jul 15; 87(2):247-52. PubMed ID: 10861483
    [Abstract] [Full Text] [Related]

  • 18. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
    Mawatari F, Tsuruta S, Ido A, Ueki T, Nakao K, Kato Y, Tamaoki T, Ishii N, Nakata K.
    Cancer Gene Ther; 1998 Jul 15; 5(5):301-6. PubMed ID: 9824049
    [Abstract] [Full Text] [Related]

  • 19. Conditionally replicative adenovirus vector carrying TRAIL gene for enhanced oncolysis of human hepatocellular carcinoma.
    Ye X, Lu Q, Zhao Y, Ren Z, Ren XW, Qiu QH, Tong Y, Liang M, Hu F, Chen HZ.
    Int J Mol Med; 2005 Dec 15; 16(6):1179-84. PubMed ID: 16273304
    [Abstract] [Full Text] [Related]

  • 20. Cell-specific expression of artificial microRNAs targeting essential genes exhibit potent antitumor effect on hepatocellular carcinoma cells.
    Mao C, Liu H, Chen P, Ye J, Teng L, Jia Z, Cao J.
    Oncotarget; 2015 Mar 20; 6(8):5707-19. PubMed ID: 25691059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.